Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?

References

• Zhang X, Li Y, Pan X, et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. Int J Radiat Oncol Biol Phys. 2010;77:357–366.
   PubMed Web of Science ®Google Scholar
• Safai S, Trofimov A, Adams JA, et al. The rationale for intensity-modulated proton therapy in geometrically challenging cases. Phys Med Biol. 2013;58:6337–6353.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59:R419–R472.
   PubMed Web of Science ®Google Scholar
• Grassberger C, Trofimov A, Lomax A, et al. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning. Int J Radiat Oncol Biol Phys. 2011;80:1559–1566.
   PubMed Web of Science ®Google Scholar
• Giantsoudi D, Grassberger C, Craft D, et al. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential. Int J Radiat Oncol Biol Phys. 2013;87:216–222.
   PubMed Web of Science ®Google Scholar
• McNamara AL, Schuemann J, Paganetti H. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data. Phys Med Biol. 2015;60:8399–8416.
   PubMed Web of Science ®Google Scholar
• Giantsoudi D, Adams J, MacDonald SM, et al. Proton treatment techniques for posterior fossa tumors: consequences for linear energy transfer and dose-volume parameters for the brainstem and organs at risk. Int J Radiat Oncol Biol Phys. 2017;97:401–410.
   PubMed Web of Science ®Google Scholar
• Kooy HM, Clasie BM, Lu H-M, et al. A case study in proton pencil-beam scanning delivery. Int J Radiat Oncol Biol Phys. 2010;76:624–630.
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44:185–205.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol. 2012;57:R99–117.
   PubMed Web of Science ®Google Scholar
• Perl J, Shin J, Schümann J, et al. TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. Med Phys. 2012;39:6818–6837.
   PubMed Web of Science ®Google Scholar
• Wigg D. Applied radiobiology and bioeffect planning. Madison, MI: Medical Physics Publishing Corporation; 2001.
   Google Scholar
• Unkelbach J, Botas P, Giantsoudi D, et al. Reoptimization of intensity modulated proton therapy plans based on linear energy transfer. Int J Radiat Oncol Biol Phys. 2016;96:1097–1106.
   PubMed Web of Science ®Google Scholar
• Cao W, Khabazian A, Yepes PP, et al. Linear energy transfer incorporated intensity modulated proton therapy optimization. Phys Med Biol. 2017;63:015013.
   PubMed Web of Science ®Google Scholar
• An Y, Shan J, Patel SH, et al. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk. Med Phys. 2017;44:6138–6147.
   PubMed Web of Science ®Google Scholar
• Giantsoudi D, Sethi RV, Yeap BY, et al. Incidence of CNS injury for a Cohort of 111 patients treated with proton therapy for medulloblastoma: LET and RBE associations for areas of injury. Int J Radiat Oncol Biol Phys. 2016;95:287–296.
   PubMed Web of Science ®Google Scholar
• Peeler CR, Mirkovic D, Titt U, et al. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016;121:395–401.
   PubMed Web of Science ®Google Scholar
• Sethi RV, Giantsoudi D, Raiford M, et al. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys. 2014;88:655–663.
   PubMed Web of Science ®Google Scholar